Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Soft tissue sarcomas of infancy.

J S Palumbo1, T Zwerdling

  • 1Department of Pediatrics, University of Cincinnati College of Medicine, Children's Hospital Medical Center, OH 45229-3039, USA.

Seminars in Perinatology
|September 4, 1999
PubMed
Summary

Neonatal soft tissue tumors are common in infants, with 15% being malignant. Early diagnosis and a multidisciplinary approach are crucial for treating these rare pediatric soft tissue sarcomas.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Protease-activated receptor-1 impedes prostate and intestinal tumor progression in mice.

Journal of thrombosis and haemostasis : JTH·2018
Same author

Platelets couple inflammation to tumorigenesis, a bridge too far.

Journal of thrombosis and haemostasis : JTH·2018
Same author

The identification of at-risk patients and prevention of venous thromboembolism in pediatric cancer: guidance from the SSC of the ISTH.

Journal of thrombosis and haemostasis : JTH·2017
Same author

Protease-activated receptor-1 inhibits proliferation but enhances leukemia stem cell activity in acute myeloid leukemia.

Oncogene·2016
Same author

Development of a new canine osteosarcoma cell line.

Veterinary and comparative oncology·2009
Same author

Factor XIII transglutaminase supports hematogenous tumor cell metastasis through a mechanism dependent on natural killer cell function.

Journal of thrombosis and haemostasis : JTH·2008

Area of Science:

  • Pediatric Oncology
  • Surgical Pathology
  • Molecular Diagnostics

Background:

  • Neonatal malignancies occur at a higher incidence compared to other pediatric age groups.
  • Soft tissue tumors constitute 25% of all infant neoplasms, with a 15% malignancy rate.
  • Distinguishing benign from malignant soft tissue lesions in neonates presents diagnostic challenges.

Purpose of the Study:

  • To review the epidemiology, differential diagnosis, evaluation, and treatment of neonatal soft tissue sarcomas.
  • To provide an in-depth discussion of common types like fibrosarcoma and rhabdomyosarcoma.
  • To highlight the role of molecular techniques and a multidisciplinary approach in managing these rare tumors.

Main Methods:

  • Literature review focusing on epidemiology, diagnosis, and treatment strategies.
  • Discussion of specific soft tissue sarcoma subtypes.
  • Integration of information on diagnostic advancements and treatment protocols.

Main Results:

  • Neonatal soft tissue sarcomas exhibit a higher incidence than in other pediatric groups.
  • Accurate differentiation between benign and malignant lesions is critical.
  • Specific subtypes like fibrosarcoma and rhabdomyosarcoma require detailed understanding.

Conclusions:

  • A comprehensive understanding of neonatal soft tissue sarcomas is essential for timely diagnosis and effective management.
  • Molecular techniques are increasingly important in the diagnostic process.
  • A multidisciplinary team approach is recommended for optimal treatment outcomes in infants with soft tissue sarcomas.

Related Experiment Videos